GCG and obesity due to melanocortin 4 receptor deficiency: Another class of anti-diabetics are the modulators of incretins, that include GLP-1 receptor agonists and DPP-4 inhibitors (vildagliptin or sitagliptin) used for T2D and obesity (in the case of GLP-1 agonists).